Home
Harrow, Inc.

Harrow, Inc. Market Share Analysis for August 2026

The Investor Relations website contains information about Harrow, Inc.'s business for stockholders, potential investors, and financial analysts.

Health > Biotechnology and Pharmaceuticals

Domainharrow.com

Year Founded1998

Employees201 - 500

Annual Revenue$200M - $500M

Harrow, Inc.

Harrow, Inc. (including company regionals)

harrow.com

See more website traffic and engagement information

Harrow, Inc. Revenue up to August 2026 is 200M - 500M

revenue generated by Harrow, Inc. top domains

Harrow, Inc. top domains revenue over 3 years

Revenue for Harrow, Inc. top domains

harrow.com200M - 500M

See more with Sales Intelligence

Total visits to Harrow, Inc.'s top domains

Understand Harrow, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

harrow.com11.2K

See more with Sales Intelligence

Avg. visit duration in Harrow, Inc.'s top domains

Analyze Harrow, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

harrow.com00:00:21

See more with Sales Intelligence

Avg. pageviews on Harrow, Inc.'s top domains

See how Harrow, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

harrow.com1.81

See more with Sales Intelligence

Harrow, Inc. top competitors by domain

Top similar sites in August 2026, ranked by their affinity

vabysmo-hcp.comCompany NameContact a Genentech Representative | ...Employees> 10001HQUnited StatesAnnual revenue--Total visits79.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Harrow, Inc.

These are the website technologies, by industry, used by Harrow, Inc. top domains

Conversion & Analytics (7)

Google Analytics

Advertising (4)

Google Adsense

Widget (3)

reCAPTCHA

Content Management System (2)

Drupal

More Technologies

6

See all

News & Signals from Harrow, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAndrew Livingston leaves Harrow, Inc. as Chief Innovation Officer.* Andrew Livingston - former Co-founder and CEO of Doxy.me, the world's largest telemedicine platform, and former Chief Innovation Officer at Harrow Health, Andrew brings deep experience in scaling digital health tools to private practices.

NewsHarrow, Inc. launched Verkazia on Jun 11th '26.Shares of Harrow Health (Nasdaq: HROW) closed up 9% at $36.47 yesterday, after it announced the re-launch of Verkazia (cyclosporine ophthalmic emulsion) 0.1%, a prescription therapy for vernal keratoconjunctivitis (VKC), a serious allergic eye disease affecting children and adults.

NewsHarrow, Inc. increased headcount by 147 on Sep 3rd '24.Harrow Health recently announced it would expand its headquarters in the Nashville area, with the effort creating 147 jobs.